WT1 Vaccination in AML and MDS: A Pilot Trial With Synthetic Analog Peptides

American Journal of Hematology - United States
doi 10.1002/ajh.24014
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

From MDS/AML to iPSC and Back Again

Science Translational Medicine
Medicine
2017English

Paclitaxel Induced MDS and AML: A Case Report and Literature Review

Case Reports in Oncological Medicine
Oncology
2016English

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Molecular Characterization of Chromosome 7 in AML and MDS Patients

African Journal of Health Sciences
2008English

Physicians Poster Session: Acute Leukemia and Secondary AML/MDS

Bone Marrow Transplantation
TransplantationHematology
2003English

Pitfalls of Vaccinations With WT1-, Proteinase3- And MUC1-derived Peptides in Combination With MontanideISA51 and CpG7909

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2010English

Discordant Expression of AC133 and AC141 in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogeneous Leukemia (AML)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy